🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/12/2006 | 41,46 | 41,65 | 41,23 | 41,60 | +0,12% | 1,01% | 6.970.458 |
| 28/12/2006 | 41,15 | 41,71 | 41,15 | 41,56 | +0,41% | 1,37% | 4.409.250 |
| 27/12/2006 | 41,03 | 41,62 | 41,03 | 41,38 | +1,36% | 1,44% | 6.752.578 |
| 26/12/2006 | 40,98 | 41,09 | 40,68 | 40,83 | -0,09% | 1,00% | 8.368.594 |
| 22/12/2006 | 41,29 | 41,43 | 40,82 | 40,87 | -1,02% | 1,48% | 7.132.164 |
| 21/12/2006 | 41,33 | 41,70 | 41,19 | 41,29 | -0,07% | 1,22% | 7.337.258 |
| 20/12/2006 | 41,39 | 41,93 | 41,27 | 41,32 | -0,48% | 1,59% | 7.759.706 |
| 19/12/2006 | 41,75 | 41,97 | 41,31 | 41,52 | -0,73% | 1,58% | 13.938.714 |
| 18/12/2006 | 41,88 | 42,05 | 41,67 | 41,82 | -0,39% | 0,91% | 11.301.003 |
| 15/12/2006 | 41,71 | 42,09 | 41,43 | 41,98 | +0,92% | 1,58% | 10.788.636 |
| 14/12/2006 | 41,33 | 41,92 | 41,32 | 41,60 | +0,60% | 1,45% | 10.184.045 |
| 13/12/2006 | 41,64 | 41,88 | 41,09 | 41,36 | -0,64% | 1,90% | 11.296.392 |
| 12/12/2006 | 42,26 | 42,41 | 41,41 | 41,62 | -0,89% | 2,37% | 11.992.474 |
| 11/12/2006 | 41,94 | 42,86 | 41,85 | 41,99 | +0,18% | 2,41% | 8.195.674 |
| 08/12/2006 | 41,78 | 42,06 | 40,99 | 41,92 | -0,05% | 2,56% | 11.910.206 |
| 07/12/2006 | 42,85 | 42,92 | 41,83 | 41,94 | -1,61% | 2,54% | 11.531.773 |
| 06/12/2006 | 42,65 | 43,05 | 42,11 | 42,62 | -1,59% | 2,21% | 15.527.482 |
| 05/12/2006 | 42,51 | 43,62 | 42,51 | 43,31 | +1,54% | 2,60% | 9.976.226 |
| 04/12/2006 | 43,24 | 43,80 | 42,27 | 42,65 | -0,80% | 3,53% | 19.618.874 |
| 01/12/2006 | 42,61 | 43,02 | 42,41 | 43,00 | +1,24% | 1,41% | 14.216.854 |
| 30/11/2006 | 42,37 | 42,69 | 42,14 | 42,47 | -0,11% | 1,31% | 10.090.144 |
| 29/11/2006 | 42,08 | 42,64 | 41,96 | 42,52 | +2,04% | 1,63% | 10.176.604 |
| 28/11/2006 | 41,72 | 41,88 | 41,38 | 41,67 | +0,11% | 1,19% | 11.171.890 |
| 27/11/2006 | 42,05 | 42,28 | 41,58 | 41,62 | -1,27% | 1,66% | 10.711.398 |
| 24/11/2006 | 41,99 | 42,30 | 41,98 | 42,16 | -0,45% | 0,75% | 2.869.529 |
| 22/11/2006 | 42,04 | 42,85 | 41,90 | 42,35 | +0,36% | 2,27% | 13.525.802 |
| 21/11/2006 | 42,37 | 42,74 | 42,08 | 42,19 | -0,79% | 1,55% | 11.447.723 |
| 20/11/2006 | 42,89 | 42,92 | 42,37 | 42,53 | -1,09% | 1,29% | 13.684.470 |
| 17/11/2006 | 42,66 | 43,00 | 42,56 | 43,00 | +0,92% | 1,03% | 10.694.106 |
| 16/11/2006 | 42,37 | 42,65 | 42,27 | 42,61 | +1,13% | 0,90% | 13.232.362 |